Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10169624

Validating radiation sterilization.

J O'Doherty
View original source ↗Export metadata ↓

Abstract

There are three aspects that manufacturers must address when validating radiation sterilization. These are the minimum dose that ensures sterility, the maximum dose at which radiation affects the functionality of the device, and the dose distribution throughout the product. This article defines a validation protocol that satisfies current radiation sterilization standards.

Explore related subjects

Equipment and SuppliesEuropeGamma RaysProduct PackagingRadiation DosageReproducibility of ResultsSterilizationJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J O'Doherty. Validating radiation sterilization.. https://pubmed.ncbi.nlm.nih.gov/10169624/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

An impact assessment of the European medical device regulations implementation - the current status quo.

BACKGROUND: This research aims to assess the current impact of the medical and in-vitro diagnostic devices regulations (MDR/IVDR) on the device industry in the EU, under the lens of postimplementation and the amending regulation, and in advance of the final transition to the IVDR/MDR in the future. RESEARCH DESIGN AND METHODS: A quantitative survey was administered to a diverse cohort of medical device enterprises, ranging from micro to large organizations. RESULTS: The survey indicates that the MDR/IVDR has harmed innovation, leading many manufacturers to seek initial device approval and launch elsewhere before in Europe. There is evidence that some manufacturers have rationalized their existing product portfolios and removed devices from the market as they stated they would in previous industry surveys. The MDR/IVDR has been shown to negatively impact manufacturers, with increased costs related to notified body (NB) fees, maintaining and updating documentation, recertification fees, and hiring additional staff. CONCLUSION: This study provides a current status of the effects of MDR/IVDR on manufacturers and finds that despite amending regulations and other interventions taken by the EU to mitigate regulatory burden, ensure product availability, and address stakeholder concerns, the EU is no longer the market of choice for new products.

Equipment and Supplies↗
PubMed1999

Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice.

The Food and Drug Administration (FDA) is publishing a list of documents issued in response to the Food and Drug Administration Modernization Act of 1997 (FDAMA), and clarifying their applicability to medical devices regulated by the Center for Biologics Evaluation and Research (CBER). This notice is intended to inform the public of the availability of these documents, clarify their scope of applicability, and to provide instructions on ways to access them.

Equipment and Supplies↗